Viewing data from:

MEDIHALER ERGOTAMINE

NDA

ERGOTAMINE TARTRATE | N012102 | 3M PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain2 active DMFs4 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

CURIA ITALY SRLERGOTAMINE TARTRATE USP/EP

DMF 229322009

TAPI NL BVERGOTAMINE TARTRATE

DMF 247822011

IVAX PHARMACEUTICALS SROInactiveERGOTAMINE TARTRATE

DMF 30381977

FARMITALIA SPAInactiveERGOTAMINE TARTRATE USP

DMF 32101978

MEDIMPEX NORTH AMERICA INCInactiveERGOTAMINE TARTRATE

DMF 33581978

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGInactiveERGOTAMINE TARTRATE

DMF 57651985

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 0.36MG/INH

0 patents0 exclusivities▴

AEROSOL, METERED;INHALATION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.